WHO Approves First Mpox Vaccine: Where Can You Get It; Price And Other Details

Mpox

Mpox

New Delhi, September 15: The World Health Organization (WHO) has recently approved the Mpox vaccine, developed by Bavarian Nordic, for use against the monkeypox virus. This is a significant development in the fight against the disease, which has been spreading rapidly across the globe. In this article, we will provide a comprehensive guide on the Monkeypox vaccine, including its price, how to take it, and what you need to know.

What is the Mpox Vaccine?

The Mpox vaccine is a live, attenuated vaccine developed by Bavarian Nordic, a Danish biotechnology company. The vaccine is designed to protect against the monkeypox virus, which is a zoonotic virus that can be transmitted from animals to humans. The vaccine has been shown to be safe and effective in clinical trials, with a high level of protection against the disease.

How Does the Vaccine Work?

The Mpox vaccine works by introducing a weakened form of the monkeypox virus to the body, which triggers an immune response. The immune system then produces antibodies that can recognize and fight the virus, providing protection against infection.

Price of the Mpox Vaccine

The price of the Mpox vaccine is expected to vary depending on the country and the supplier. However, according to reports, the vaccine is expected to be priced around $100-$150 per dose.

How to Take the Vaccine

The Mpox vaccine is administered in two doses, with the second dose given 28 days after the first dose. The vaccine is given as an injection into the muscle of the upper arm.

Side Effects of the Mpox Vaccine

Like any vaccine, the Monkeypox vaccine can cause side effects, which are usually mild and temporary. Common side effects include:

 1. Pain, redness, or swelling at the injection site

 2. Fatigue

 3. Headache

4. Muscle pain

5. Fever

Who Should Take the Mpox Vaccine?

The Mpox vaccine is recommended for individuals who are at high risk of exposure to the monkeypox virus, including:

1. Healthcare workers.

2. Laboratory workers.

3. Individuals who work with animals that may be infected with the virus.

4. Individuals who have been exposed to someone with monkeypox.

The approval of the Monkeypox vaccine by the WHO is a significant development in the fight against the monkeypox virus. The vaccine has been shown to be safe and effective, and it is expected to play a critical role in controlling the spread of the disease. If you are at high risk of exposure to the monkeypox virus, it is essential to consult with your healthcare provider to determine if the Monkeypox vaccine is right for you.

Exit mobile version